BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//InvisionCommunity Events 4.7.23//EN
METHOD:PUBLISH
CALSCALE:GREGORIAN
REFRESH-INTERVAL:PT15M
X-PUBLISHED-TTL:PT15M
X-WR-CALNAME:Community Calendar
NAME:Community Calendar
BEGIN:VTIMEZONE
TZID:Europe/London
TZURL:http://tzurl.org/zoneinfo/Europe/London
X-LIC-LOCATION:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20220327T020000Z
RRULE:FREQ=YEARLY;BYMONTH=3;BYDAY=-1SU
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20221030T020000Z
RRULE:FREQ=YEARLY;BYMONTH=10;BYDAY=-1SU
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
SUMMARY:​​​​​​Webinar - Injectable therapies across the 
	lipid management pathway
DTSTAMP:20220608T130251Z
SEQUENCE:0
UID:816-1-ee2a5ec9cbd1b5a75b4ec5d63ec903ec@www.pslhub.org
ORGANIZER;CN="Patient-Safety-Learning":noreply@pslhub.org
DESCRIPTION:\n	Collaboration to deliver NHS Long Term Plan goals on CVD 
	and Population Health Management\n\n\n\n	A novel injectable treatment for 
	people at risk of cardiovascular disease is being made available to patien
	ts more quickly\, thanks to a three-way agreement between NHS England and 
	NHS Improvement\, the AHSN Network and the pharmaceutical company\, Novart
	is.\n\n\n\n	Inclisiran is the first of a new type of cholesterol-lowering 
	therapy\, which uses RNA interference (RNAi) to boost the liver’s abilit
	y to remove harmful cholesterol from the blood. It can be given to people 
	with high cholesterol who have already had a previous cardiovascular event
	 to reduce the chances of them having another.\n\n\n\n	This webinar will i
	ntroduce this innovative injectable therapy\, explore it’s its place on 
	the treatment pathway\, and how it can support both the NHS Long Term Plan
	 dual ambitions of reducing cardiovascular disease and through Population 
	Health Management.\n\n\n\n	Register for the webinar\n\n
DTSTART:20220608T113000Z
DTEND:20220608T123000Z
END:VEVENT
END:VCALENDAR